Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

BFRI
Biofrontera Inc. Common Stock
stock NASDAQ

At Close
Jul 3, 2025 11:55:35 AM EDT
0.7200USD+4.912%(+0.0339)106,861
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Jul 3, 2025 8:34:30 AM EDT
0.7250USD+5.057%(+0.0349)1,630
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
09:29AM EST  Biofrontera Reports Issued Letter To Shareholders Highlighting 2021 Successes, Outlining Strategic Plan For 2022, Beyond   Benzinga
09:26AM EST  Biofrontera Inc. (Nasdaq: BFRI) (the Company), a biopharmaceutical company specializing in the commercialization of dermatological products, today issued the following letter from CEO Erica Monaco and Executive Chairman of the Board Hermann Lbbert.   GlobeNewswire Inc
Jan 13, 2022
11:48AM EST  Biofrontera Sees Q4 Sales $9.1M-$9.2M vs $10.8M Estimate; FY21 Sales $24.1M-$24.2M vs $26M Est.   Benzinga
08:45AM EST  Biofrontera Inc. (Nasdaq: BFRI) (the Company), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced preliminary, unaudited revenue for the quarter and full year ended December 31, 2021.   GlobeNewswire Inc
Jan 10, 2022
08:45AM EST  Biofrontera Inc. (Nasdaq: BFRI) (the Company), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that it plans to participate in the following two dermatology conferences in January:   GlobeNewswire Inc
Dec 30, 2021
02:38PM EST  Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Future FinTech Shares Spike Higher   Benzinga
08:47AM EST  UPDATE: Biofrontera Is No Longer Considered A Subsidiary Of Biofrontera AG   Benzinga
08:45AM EST  Biofrontera Announces Reduction Of Biofrontera AG Shareholding To Less Than 50% Through Warrant Exercises   Benzinga
08:45AM EST  Biofrontera Inc. announces reduction of Biofrontera AG   GlobeNewswire Inc
Dec 28, 2021
12:14PM EST  Mid-Day Market Update: Crude Oil Rises 1%; Baudax Bio Shares Plummet   Benzinga
10:51AM EST  Mid-Morning Market Update: Markets Mostly Higher; Digital Turbine Reports Multi-Year Collaboration With Google   Benzinga
Dec 23, 2021
02:24PM EST  'Biofrontera May Be A $40+ Stock In The Short-Term, But Its Strong Fundamentals Make The Company A Fit For The Long-Term Investor Too' -Seeking Alpha Blog Post From Contributor biotechplayer123   Benzinga
Dec 21, 2021
10:12AM EST  Mid-Morning Market Update: Markets Open Higher; General Mills Earnings Miss Views   Benzinga
Dec 15, 2021
02:34PM EST  Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update   Benzinga
12:52PM EST  Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb   Benzinga
10:20AM EST  Mid-Morning Market Update: Markets Open Lower; US Retail Sales Miss Estimates   Benzinga
10:05AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021   Benzinga
06:52AM EST  Benchmark Initiates Coverage On Biofrontera with Buy Rating, Announces Price Target of $11   Benzinga
Dec 13, 2021
10:00AM EST  Shares of Biofrontera Inc. (BFRI) are rising more than 13% in the morning trade on Monday.   RTTNews
09:15AM EST  Biofrontera AG Enrolls First Patient To Phase IIb Clinical Study Evaluating Ameluz / BF-RhodoLED For Acne   Benzinga
09:09AM EST  Biofrontera Inc. Announces Enrollment of First Subject in Phase 2b   GlobeNewswire Inc
Dec 10, 2021
09:53AM EST  Mid-Morning Market Update: Markets Open Higher; Inflation Rate Increases To 6.8%   Benzinga
Dec 8, 2021
09:34AM EST  Biofrontera Announces Notice Of Allowance For U.S. Method-of-Use Patent On PDT-Lamp. BZ NOTE: Benzinga Reported This Patent On Dec. 2   Benzinga
09:32AM EST  Biofrontera Inc. Announces Notice of Allowance for U.S.   GlobeNewswire Inc
Dec 6, 2021
11:43AM EST  Biofrontera AG Announced Eenrollment of First Patient in Phase I Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz   Benzinga
11:36AM EST  Biofrontera Earlier Announced Enrollment Of 1st Subject In Phase 1 Safety Study Evaluating Photodynamic Therapy With 3 Tubes Of Ameluz   Benzinga
09:00AM EST  Biofrontera Inc. Enrolls First Subject in Phase 1 Safety Study   GlobeNewswire Inc
Dec 2, 2021
02:51PM EST  Mid-Afternoon Market Update: Dow Jumps Over 600 Points; Kroger Shares Spike Higher   Benzinga
12:12PM EST  Mid-Day Market Update: Express Rises Following Q3 Earnings; Context Therapeutics Shares Plummet   Benzinga
10:25AM EST  Mid-Morning Market Update: Markets Mostly Higher; Dollar General Posts Upbeat Q3 Earnings   Benzinga
09:16AM EST  Biofrontera Announces Notice Of Allowance For U.S. Patent Titled 'Illumination for Photodynamic Therapy'   Benzinga
09:15AM EST  Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on   GlobeNewswire Inc
Dec 1, 2021
07:05PM EST  Biofrontera Inc. Announces Closing of $15 Million Private Placement   GlobeNewswire Inc
Nov 30, 2021
04:49PM EST  Biofrontera Q3 EPS $(2.00), Sales $4.30M   Benzinga
04:04PM EST  Mid-Morning Market Update: Markets Open Higher; Li Auto Sales Top Views   Benzinga
04:04PM EST  CORRECTION: Biofrontera Inc Ticker Is 'BFRI'   Benzinga
04:03PM EST  Biofrontera Prices 2,857,143 Private Placement At $5.25/Share   Benzinga
09:20AM EST  Biofrontera Inc. Reports Third Quarter 2021 Financial Results and   GlobeNewswire Inc
Nov 29, 2021
09:27AM EST  Biofrontera Inc. Pricing of $15 Million Private Placement Priced   GlobeNewswire Inc
Nov 26, 2021
10:13AM EST  Mid-Morning Market Update: Markets Open Lower; Europe's Regulator Backs Pfizer's COVID-19 Vaccine For Kids Aged 5-11 Years   Benzinga
Nov 24, 2021
03:04PM EST  Mid-Afternoon Market Update: Dow Falls 75 Points; Biofrontera Shares Spike Higher   Benzinga
12:32PM EST  Mid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump   Benzinga
10:23AM EST  Mid-Morning Market Update: Markets Open Lower; Deere Earnings Top Views   Benzinga
10:18AM EST  Biofrontera Continues Rally   RTTNews
10:06AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021   Benzinga
09:18AM EST  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Nov. 24, 2021: KTTA, APVO, TSLA, BFRI, OCUP   Benzinga
08:02AM EST  Roth Capital Initiates Coverage On Biofrontera with Buy Rating, Announces Price Target of $20   Benzinga
Nov 23, 2021
08:15AM EST  Biofrontera Inc. to Report Third Quarter Financial Results on   GlobeNewswire Inc
Nov 21, 2021
03:05PM EST  The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week   Benzinga
Nov 16, 2021
09:12AM EST  Biofrontera Kicks Off U.S. Clinical Study Program For Ameluz   Benzinga
Nov 2, 2021
02:45PM EDT  Biofrontera Inc. Announces Closing of Initial Public Offering and   GlobeNewswire Inc
Oct 29, 2021
10:20AM EDT  Biofrontera Shares Open For Trade At $4.09; IPO Priced $5/Unit   Benzinga
Oct 18, 2021
07:34AM EDT  The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC